CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Critical Thinking on Criticality

“Critical” is a widely used term in Quality by Design, relating to anything which affects the safety or efficacy of the finished product. Dr. Brian Carlin at FMC BioPolymer explains why Critical Process parameters and Critical Material Attributes must be controlled to ensure the finished product Critical Quality Attributes necessary for safety and efficacy, as prospectively summarized in the Quality Target Product Profile.
https://international-pharma.com/wp-content/uploads/2014/01/Critical.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026